Victoria Vakiener is Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR). They have made 1 open-market trade across 1 company since 2021, most recently 2025-12-19.
CIK 0001826263
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARWR | SELL · 10b5-1 | 2025-12-19 | 2025-12-23 | $67.68 | $1.4M | +3.4% | +1.6% | -17.2% |
| ARWR | SELL · 10b5-1 | 2024-12-16 | 2024-12-18 | $21.91 | $394K | -7.5% | -3.7% | -25.7% |
| ARWR | SELL · 10b5-1 | 2024-05-02 | 2024-05-06 | $23.31 | $42K | -0.6% | +0.4% | -0.3% |
| ARWR | SELL · 10b5-1 | 2024-01-11 | 2024-01-16 | $38.00 | $317K | -4.8% | -14.0% | -30.2% |
| ARWR | SELL | 2023-09-28 | 2023-10-02 | $26.33 | $41K | -0.7% | -1.1% | +18.9% |
| EPZM | SELL · 10b5-1 | 2021-02-04 | 2021-02-05 | $11.21 | $9K | -4.0% | -19.3% | -38.8% |
| EPZM | SELL · 10b5-1 | 2021-01-25 | 2021-01-27 | $11.41 | $7K | -2.4% | -19.3% | -31.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.